Timothy L. Moore
CIK 1669207 · Chief Technical Officer · last filed 2026-10-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
KITE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2225 COLORADO AVE.
SANTA MONICA, CA 90404
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) Delisted | Director | 0 | $38.61 | $0 | $0 | 8 | 2026-10-08 |
| CERS | Director | 205,073 | $1.91 | $391.7K | $32.2K | 14 | 2025-06-04 |
| ALLO | Chief Technical Officer | 250,713 | $0.67 | $167.5K | -$25.2K | 4 | 2025-02-05 |
| TIL | Chief Operating Officer | — | $5.65 | — | $0 | 1 | 2022-09-06 |
| Kite Pharma, Inc. (KITE) Delisted | EVP, Technical Operations | 45,661 | — | — | -$3.34M | 5 | 2017-09-27 |
Recent Filings · Page 3 of 4
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-03 | CERS | Mixed | +28,116 | $0 | EDGAR |
| 2020-09-08 | CERS | Exer (M) | +4,296 | $0 | EDGAR |
| 2020-06-05 | CERS | Grant (A) | — | $0 | EDGAR |
| 2020-02-13 | CERS | Buy (P) | +3,614 | $17.2K | EDGAR |
| 2020-02-13 | CERS | Buy (P) | — | $0 | EDGAR |
| 2020-02-03 | CERS | Buy (P) | +3,614 | $15.0K | EDGAR |
| 2019-09-10 | CERS | Exer (M) | +4,297 | $0 | EDGAR |
| 2019-06-07 | CERS | Grant (A) | — | $0 | EDGAR |
| 2018-09-07 | CERS | Grant (A) | — | $0 | EDGAR |
| 2017-10-05 | — | Mixed | −45,661 | -$706.9K |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).